Real World Evidence Solutions Market by Component (Data Sets and Services), by Therapeutic Area (Oncology, Cardiovascular Disease, Neurology, Immunology, and Others), and by End-Users (Pharmaceutical and Medical Device Companies, Healthcare Payers, Healthcare Providers, and Others)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020 - 2029

                                          
Abstract
                    
The report covers forecast and analysis for the real world evidence solutions market on a global and regional level. The study provides historic data for 2016 and 2017 along with a forecast from 2018 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the real world evidence solutions market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the real world evidence solutions market on a global level.

In order to give the users of this report a comprehensive view of the real world evidence solutions market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein component, therapeutic areas, and end-user segments are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology and regional expansion of major participants involved in the market on global and regional basis. Moreover, the study covers price trend analysis, component portfolio of various companies according to region.

The study provides a decisive view of the real world evidence solutions market by segmenting the market based on component, therapeutic areas, end-users, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2026. Based on component, the market is segmented into data set and services. The data set segment is further sub-segmented into clinical setting data, claims data, pharmacy data, and patient powered data. On the basis of the therapeutic area, the global market is segmented into oncology, cardiovascular disease, neurology, immunology, and others. Based on end-users, the market is segmented as pharmaceutical and medical device companies, healthcare payers, healthcare providers, and others. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further division into major countries including the U.S., Rest of North America, U.K., Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, southeast Asia, Rest of Asia Pacific, Brazil, Rest of Latin America, GCC Countries, South Africa and Rest of the Middle East and Africa. This segmentation includes demand for real world evidence solutions market based on individual component, therapeutic areas, and end-user in all the regions and countries.

The report also includes detailed profiles of end players such as IQVIA, International Business Machines Corporation, ICON, PAREXEL, Pharmaceutical Product Development, Optum, Cognizant, Oracle, SAS, Syneos Health, Clinigen Group, Palantir Technologies, and Flatiron Health, among others.

This report segments the global real world evidence solutions market as follows:

Global Real World Evidence Solutions Market: Component Segment Analysis

	Data Sets  
	
		Clinical Setting Data
		Claims Data
		Pharmacy Data
		Patient Powered Data
	
	
	Services 

Global Real World Evidence Solutions Market: Therapeutic Area Segment Analysis

	Oncology
	Cardiovascular Disease
	Neurology
	Immunology
	Others Therapeutic Areas

Global Real World Evidence Solutions Market: End-user Segment Analysis

	Pharmaceutical and Medical Device Companies
	Healthcare Payers
	Healthcare Providers
	Others

Global Real World Evidence Solutions Market: Regional Segment Analysis

	North America
	
		The U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	Middle East and Africa